Impact of low-level electromagnetic fields on the inducibility of atrial fibrillation in the electrophysiology laboratory

Abstract

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

A subspace projection approach to quantify respiratory variations in the f-wave frequency trend

“…Further, it has been shown that AF progression through cellular remodeling could be reduced by minimizing sympathetic or increasing parasympathetic tone ( Bashir et al, 2019 ). In a recent study ( Sohinki et al, 2021 ), investigated the impact of low-level electromagnetic fields (LL-EMF) which is specifically targeted for vagal stimulation, on AF inducibility in humans.…”

Non-invasive Neuromodulation of Arrhythmias

“…Sohinki et al recently investigated the ability of LL-EMF to attenuate pacing-induced AF in patients presenting for AF ablation. 66 In response to 60 min of LL-EMF stimulation applied over the head and neck, they were able to demonstrate reductions in the duration of pacing-induced AF (11.0 ± 3.43 min; P = .03), ectopic firing initiating spontaneous episodes of AF, and reductions in levels of the chemoattractant molecule monocyte chemoattractant protein-1. 66 …”

Electromagnetic field and cardiovascular diseases: A state‐of‐the‐art review of diagnostic, therapeutic, and predictive values

“…The study showed that external EMF (applied around the head) with a strength of 0.032 μG at a frequency of 0.89 Hz, applied before ablation, could suppress the inducibility of AF. 72 Based on the proof-of-concept studies conducted, EMF appears to be a promising noninvasive approach to managing AF by inhibiting the activity of extrinsic and intrinsic cardiac ANS. However, more large-scale human studies are necessary to evaluate its efficacy in improving clinical outcomes for AF.…”

“…EMF was applied to the bodies of the patients to influence the neural networks that innervate the heart. The study showed that external EMF (applied around the head) with a strength of 0.032 μG at a frequency of 0.89 Hz, applied before ablation, could suppress the inducibility of AF 72 . Based on the proof‐of‐concept studies conducted, EMF appears to be a promising noninvasive approach to managing AF by inhibiting the activity of extrinsic and intrinsic cardiac ANS.…”